In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Featured Stories

How Proximity Creates Partnerships

Former Amgen R&D lead Sean Harper talks exclusively to In Vivo about his new role as a venture capitalist, joining veteran industry investor Beth Seidenberg as co-founder of Los Angeles-based Westlake Village BioPartners.

Business Strategies Deals

MHealth And Research In Oncology

The World Health Organization defines mobile health (mHealth) as a “medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants, and other wireless devices.”

Digital Health Innovation Personalized Medicine

The Future Of AI Use In Endoscopy

Medtronic has launched a new artificial intelligence enhanced endoscopy system in Europe for recognizing pre-cancerous polyps. The gastroenterology community recently convened at an expert panel discussion hosted by Medtronic during UEG Week to discuss the future of AI in endoscopy.

Artificial Intelligence Commercial Innovation

Putting The Patient First: The Challenge And Opportunities To Improve Rare-Disease Therapy Development

Advances in identifying the genetic causes of diseases, and particularly cancers, coupled with regulatory incentives to encourage the development of therapeutic approaches to once poorly managed orphan diseases have fueled a surge in exciting new medicines. To address some of these issues and explore potential solutions, Simbec-Orion in collaboration with Informa Pharma Intelligence convened a round table of experts attending the BIO International Convention

Read More

Recent Issues

Growth Explore this Topic

Set Alert for Growth

Latest From Growth

PureTech’s Problem-Solving Skills Target The BIG Picture

PureTech Health has amassed niche expertise and built a unique structure that allows it to develop technologies for unmet needs, in the separate but related areas of brain-immune-gut. And now, with the experienced ex-Sanofi CEO Chris Viehbacher as interim chair, PureTech can target a smooth path to its next growth stages in the “BIG Axis.” Senior executives Eric Elenko and Joep Muijrers reveal more about the focus and aims of the Boston, US group.

C-Suite Speaks Business Strategies

MorphoSys: A European Champion Crossing The Biopharma Rubicon

The Munich-based company is one of a handful of mature European biotechs poised to enter the big league. New CEO Jean-Paul Kress talks to In Vivo about the firm’s next generation antibody platform and why US expansion is crucial to its future.

BioPharmaceutical C-Suite Speaks

The Case For Agile Innovation In Health Care

In a recent Bain & Company survey, nearly 80% of health care executives said they needed to be more agile. Yet more than half said they were not familiar with formal agile methodologies and tools, and were not using them in their companies.

Growth Commercial

Innovation Explore this Topic

Set Alert for Innovation

Latest From Innovation

Digital Labels: Reimagining Product Information To Improve Outcomes

The rules behind product labeling have not undergone any significant revisions in the US and Europe for many years, but is this about to change?

Digital Health Innovation

C-Suite Snippets: Open Data And Innovation

In case you missed it: catch up with snippets from interviews published by In Vivo this month.

BioPharmaceutical Medical Device

Why Reusable Data Matters For Future Of Pharma

Castor, a cloud-based data solution, is enabling researchers to effectively capture and integrate data from any source. CEO and founder of the company, Derk Arts, spoke to In Vivo about the importance of cohesive data for the future use of artificial intelligence in biopharma.

Digital Health Research and Development Strategies

Leadership Explore this Topic

Set Alert for Leadership

Latest From Leadership

Sony’s AV Tech Propels Medical Unit

Audiovisual media solutions provider Sony Corp. plays a largely unseen role in the success of end-user-facing capital equipment that manufacturers serve to the medtech sector. Product marketing manager for Sony Europe Healthcare Solutions, John Herman, explains Sony’s role in the industry, and how it is stepping up its focus on 4K imaging.

Business Strategies Digital Health

Execs On The Move, October 2019

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments Leadership

How Proximity Creates Partnerships

Former Amgen R&D lead Sean Harper talks exclusively to In Vivo about his new role as a venture capitalist, joining veteran industry investor Beth Seidenberg as co-founder of Los Angeles-based Westlake Village BioPartners.

Business Strategies Deals

Market Access Explore this Topic

Set Alert for Market Access

Latest From Market Access

From US To EU: Young Biotechs Going It Alone

Europe’s patchwork of reimbursement agencies make it a daunting place for a small US biotech to do business. Traditionally large pharma partners or CMSOs have provided an experienced hand to hold, but as a new wave of gene therapies and orphan drugs get the EMA green light, smaller drug developers are applying innovation to commercialization and choosing to go solo.

Strategy Rare Diseases

Fully-Connected Data Infrastructure Offering Will Support Individualized Cancer Therapies

A new digital ecosphere to support the efficient delivery of individualized cancer therapies to patients has been released by data and information management company EY. It is an open source framework that can be accessed by all stakeholders in the care delivery chain.

Market Access Artificial Intelligence

C-Suite Snippets: Planning For The Future Cancer Market

In case you missed it: catch up with snippets from interviews published by In Vivo this week.

Market Access Research and Development Strategies

Market Intelligence Explore this Topic

Set Alert for Market Intelligence

Latest From Market Intelligence

Biopharma Quarterly Dealmaking Statistics, Q3 2019

During Q3, biopharma company fundraising reached $13.3bn, mostly from follow-on public offerings, which again made up the most of those dollars. Despite numerous deals valued at $100m+, M&A activity was the lowest of the year. Many of the biggest partnership deals were centered around the inflammation/immune area.

Deals Market Intelligence

Deals In Depth: September 2019

Sumitomo Dainippon Pharma paid $3bn up front in a wide-ranging deal involving multiple "vant" companies owned by Roivant. Lundbeck acquired what could be an important asset in the CGRP migraine market with the takeover of Alder for nearly $2bn in up-front and earn-out payments. Device financing surpassed pharma financing due to a $2bn debt offering by Alcon.

Deals Market Intelligence

C-Suite Snippets: Conducting Due Diligence In Era Of Accelerated Science

In the most recent installment of In Vivo's VC Playbook column, former Amgen R&D lead Sean Harper talks exclusively about his new role as a venture capitalist, joining veteran industry investor Beth Seidenberg as co-founder of Los Angeles-based Westlake Village BioPartners.

Business Strategies Commercial
UsernamePublicRestriction

Register